• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Medical Devices

  • Print
  • Share
  • E-mail

Siemens Mammomat Novation DR Full Field Digital Mammography System - PMA P030010

photo of Siemens Mammomat Novation DR Full Field Digital Mammography System - PMA P030010This is a brief overview of information related to FDA's approval to market this product. See the links below to the Summary of Safety and Effectiveness and product labeling for more complete information on this product, its indications for use, and the basis for FDA's approval.


Applicant: Siemens MedicalSolutions USA, Inc.
Address: 51 Valley Stream Parkway Malvern , PA 19355
Approval Date: August 20, 2004
Approval Letter: http://www.accessdata.fda.gov/cdrh_docs/pdf3/P030010a.pdf

What is it? Like regular mammography, digital mammography produces pictures of the breast using X-rays. Instead of film, this process uses detectors that change the X-rays into electrical signals, which are then converted to an image. Digital mammography is used for both screening and diagnosis. For the patient, the procedure is the same as with ordinary mammography. The Siemens Mammomat Novation DR Full Field Digital Mammography System (Novation DR) is used with an approved X-ray system, the Siemens Mammomat 3000 Nova mammography system, which was cleared by the FDA.

 How does it work? The device passes X-rays through the breast tissue to the digital receptor which converts the X-ray energy to numbers, processes the numbers, and produces an image that can be viewed at a work station or sent to a film printer.

 When is it used? The device is used to screen and diagnose breast cancer just as regular analog (film) mammography.

 What will it accomplish? The Novation DR System has been shown to be effective in the detection of breast cancer and other abnormalities.  

When should it not be used? For women who need mammographic screening or diagnosis, there there are no contraindications for this device.  

Additional information: Summary of Safety and Effectiveness Data and labeling are available at: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cftopic/pma/pma.cfm?num=p030010

-

Other Resources

-